Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  American Journal of Pathology

• Publication date

  1988-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2451427PMCID PMC1880562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclosporin A does not inhibit epidermal growth at therapeutic levels.

  1988cited by this paper
• Cyclosporin A does not inhibit epidermal cell growth at therapeutic levels.

  1987cited by this paper
• The effects of cyclosporin A on T lymphocyte and dendritic cell sub‐populations in psoriasis

  1987cited by this paper
• The cyclosporins inhibit lymphocyte activation at more than one site.

  1987cited by this paper
• Thymic and lymphoid changes and serum immunoglobulin abnormalities in mice receiving cyclosporine.

  1987cited by this paper
• Inhibition of the proliferation of transformed epidermal cells in culture by various prostaglandins.

  1987cited by this paper
• Effects of cyclosporin A on a kidney epithelial cell line (LLC-PK1).

  1987cited by this paper
• Effects of cyclosporin A on a kidney epithelial cell line (LLC-PK1).

  1987cited by this paper
• The effect of Goeckerman therapy on interferon in serum and suction blister fluid from patients with psoriasis

  1986cited by this paper
• Cyclosporin-induced endothelial cell injury.

  1986cited by this paper
• Human keratinocyte-lymphocyte reactions in vitro.

  1986cited by this paper
• Dermatologic applications of cyclosporine.

  1986cited by this paper
• Clearance of psoriasis with low dose cyclosporin.

  1986cited by this paper
• Cyclosporine improves psoriasis in a double-blind study.

  1986cited by this paper
• Effects of ultraviolet radiation and immunosuppressive therapy on mouse epidermal cell kinetics

  1986cited by this paper
• Immunomodulatory and antiproliferative effect of recombinant alpha, beta, and gamma interferons on cultured human malignant squamous cell lines, SCL-1 and SW-1271.

  1985cited by this paper
• Improvement of ichthyosis by cyclosporin.

  1985cited by this paper
• Lymphocyte-keratinocyte interactions mediated through interferon. New observations relevant to psoriasis.

  1984cited by this paper
• Antiproliferative effects of recombinant alpha- and gamma-interferons on cultured human keratinocytes.

  1984cited by this paper
• Interferon in suction blister fluid from psoriatic lesions

  1983cited by this paper
• Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture.

  1983cited by this paper
• Cyclosporin A for psoriasis.

  1979cited by this paper
• CYCLOSPORIN A: AN IMMUNOSUPPRESSIVE AGENT PREFERENTIALLY ACTIVE AGAINST PROLIFERATING T CELLS

  1979cited by this paper
• Isolation and growth of adult human epidermal keratinocytes in cell culture.

  1978cited by this paper
• Effects of the new anti-lymphocytic peptide cyclosporin A in animals.

  1977cited by this paper

• Effect of Tacrolimus on Development of Experimental Cholesteatoma.

  2025cites this paper
• In vitro study on immune response modifiers as novel medical treatment options for cholesteatoma.

  2021cites this paper
• This article has been retracted: A preliminary examination of the role of NFAT 3 in human skin, cultured keratocytes and dermal fibroblasts

  2010cites this paper
• Skin inflammatory disorders

  2006cites this paper
• Cyclosporin A, FK506 and dithranol alter tyrosine-specific protein phosphorylation in HaCaT keratinocytes

  2005cites this paper
• Histological and ultrastructural effects of cyclosporin A on normal human skin xenografted on to nude mice

  2005cites this paper
• Growth inhibition of human gastrointestinal cancer cells by cyclosporin A

  2005cites this paper
• A cyclosporine-sensitive psoriasis-like disease produced in Tie2 transgenic mice.

  2005cites this paper
• Effect of cyclosporins A, G, and H on normal and ichthyotic keratinocyte growth in culture

  2004cites this paper
• Comparison of antiproliferative effects of experimental and established antipsoriatic drugs on human kerationocytes, using a simple 96-well-plate assay

  2003cites this paper
• The New Angiotherapy

  2002cites this paper
• Cyclosporine Inhibits Growth through the Activating Transcription Factor/cAMP-responsive Element-binding Protein Binding Site in the Cyclin D1 Promoter*

  2002cites this paper
• Receptor Tyrosine Kinases in Angiogenesis

  2002cites this paper
• Cyclosporin a promotes hair epithelial cell proliferation and modulates protein kinase C expression and translocation in hair epithelial cells.

  2001influential citation
• Basal keratinocytes from uninvolved psoriatic skin exhibit accelerated spreading and focal adhesion kinase responsiveness to fibronectin.

  2001cites this paper
• Cyclin D1, B and A expression and cell turnover in psoriatic skin lesions before and after cyclosporin treatment

  2000cites this paper
• Caspase inhibitor blocks human immunodeficiency virus 1-induced T-cell death without enhancement of HIV-1 replication and dimethyl sulfoxide increases HIV-1 replication without influencing T-cell survival.

  2000cites this paper
• Antiangiogenesis by cyclosporine.

  1998cites this paper
• UVB-induced alterations in permeability barrier function: roles for epidermal hyperproliferation and thymocyte-mediated response.

  1997cites this paper
• Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.

  1997cites this paper
• Differences in reactivity to cyclosporin A and interferon-gamma of normal and HPV-transformed keratinocytes.

  1996cites this paper
• FK506 and cyclosporin A inhibit growth factor-stimulated human keratinocyte proliferation by blocking cells in the G0/G1 phases of the cell cycle.

  1996cites this paper
• In vivo pharmacological effects of ciclosporin and some analogues.

  1996cites this paper
• Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens.

  1996cites this paper
• Cyclic 3,5 adenoise monophosphate and cyclosporin A inhibit cellular proliferation and serine/threonine protein phosphatase activity in pituitary cells.

  1996cites this paper
• Cyclosporin protects the eyelid skin from injury after injection of doxorubicin.

  1995cites this paper
• Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study.

  1994cites this paper
• Potentializing effect of ketoconazole on cyclosporin A-induced inhibition of keratinocyte DNA synthesis.

  1994cites this paper
• Cyclosporin A inhibits keratinocyte cytokine gene expression

  1994cites this paper
• Response of the clinically uninvolved skin of psoriatic patients to repeated tape stripping during cyclosporin A treatment

  1994cites this paper
• The mechanisms of action of cyclosporin A in the treatment of psoriasis.

  1993cites this paper
• Cyclosporin in psoriasis: pathophysiology and experimental data.

  1993cites this paper
• Accessory cell function of keratinocytes for superantigens. Dependence on lymphocyte function-associated antigen-1/intercellular adhesion molecule-1 interaction.

  1993cites this paper
• Cyclosporine therapy for psoriasis: a cell cycle-derived dosing schedule.

  1992cites this paper
• Pharmacology and Therapeutic Use in Autoimmune Diseases

  1992cites this paper
• The immunology of psoriasis

  1992cites this paper
• Cyclosporine is angiostatic

  1992cites this paper
• Effect of cyclosporin on vascular smooth muscle cells.

  1991cites this paper
• Drug-induced gingival overgrowth: old problem, new problem.

  1991cites this paper
• [Cyclosporine A in dermatology].

  1991cites this paper
• Cyclosporine in psoriasis treatment. Inhibition of keratinocyte cell-cycle progression in G1 independent of effects on transforming growth factor alpha/epidermal growth factor receptor pathways.

  1991cites this paper
• [Non-immunologic effects of cyclosporins].

  1991cites this paper
• Does prolactin play a role in skin biology and pathology?

  1991cites this paper
• Cyclosporin A suppresses ICAM-1 expression by papillary endothelium in healing psoriatic plaques.

  1991cites this paper
• Adhesion molecule expression in psoriatic skin lesions and the influence of cyclosporin A

  1991cites this paper
• The cytokine network in psoriasis.

  1991cites this paper
• A new perspective on canine keratoconjunctivitis sicca. Treatment with ophthalmic cyclosporine.

  1990cites this paper
• Intracellular targets of cyclosporine.

  1990cites this paper
• Cyclosporin a exerts a cytostatic effect in vivo on human and murine epithelial cells

  1990cites this paper
• Direct antiproliferative effect of cyclosporin A on cultured keratinocytes and fibroblasts

  1990cites this paper
• Cyclosporine A in the treatment of psoriasis: a clinical and mechanistic perspective.

  1990cites this paper
• The effect of cyclosporin A on proliferation and differentiation-associated antigens of normal human skin xenografted onto nude mice.

  1990cites this paper
• Cyclophilin content of normal and psoriatic epidermis.

  1990cites this paper
• Mechanisms of cyclosporine A inhibition of antigen-presenting activity in uninvolved and lesional psoriatic epidermis.

  1990cites this paper
• Effects of cyclosporin A on cultured human epidermal keratinocytes. Growth and 5-bromo-2'-deoxyuridine incorporation.

  1990cites this paper
• Vascular effects of cyclosporine A in vivo and in vitro.

  1990cites this paper
• Immunohistochemical analysis of effects of cyclosporin A on gingival epithelium.

  1990cites this paper
• Time‐dependent inhibition of growth of human keratinocytes and fibroblasts by cyclosporin A: effect on keratinocytes at therapeutic blood levels

  1990cites this paper
• New developments in our understanding of the biology of psoriasis.

  1990cites this paper
• Differential effects of cyclosporine A on ornithine decarboxylase activity induced by ultraviolet-B and PUVA in mouse skin.

  1990cites this paper
• Cyclosporine. An immunosuppressant affecting epithelial cell proliferation.

  1990cites this paper
• Pityriasis rubra pilaris in Indians

  1990cites this paper
• Cyclosporine in lamellar ichthyosis.

  1989cites this paper
• Inhibition of 125I-epidermal growth factor binding to cultured keratinocytes by antiproliferative molecules gamma interferon, cyclosporin A, and transforming growth factor-beta.

  1989cites this paper
• Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis.

  1989cites this paper
• Cyclosporin A inhibits directly in vivo keratinocyte proliferation of living human skin.

  1989cites this paper
• Cyclosporin A does not modify Langerhans' cell number and distribution in normal human skin.

  1989cites this paper
• Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.

  1989cites this paper
• Pharmacology of cyclosporine (sandimmune). IV. Pharmacological properties in vivo.

  1989cites this paper
• Experimental analysis of the effects of cyclosporine on the induction and growth of epithelial tumors.

  1989cites this paper
• The induction of anagen hair growth in telogen mouse skin by cyclosporine A administration.

  1989cites this paper
• The flip side of tumor immunity.

  1989cites this paper
• Cyclosporine inhibits basic fibroblast growth factor-driven proliferation of human endothelial cells and keratinocytes.

  1989cites this paper
• Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis.

  1989cites this paper
• Cyclosporin A: recent developments in the mechanism of action and clinical application.

  1989cites this paper
• The systemic administration of gamma interferon inhibits collagen synthesis and acute inflammation in a murine skin wounding model.

  1989cites this paper
• Levels of cyclosporin in epidermis of treated psoriasis patients differentially inhibit growth of keratinocytes cultured in serum free versus serum containing media.

  1988cites this paper